Relevant: How the drug solutions business located itself ready for just a pandemic The team is also communicating for the FDA the value of the earlier one-way links in the pharmaceutical source chain. “There are many of raw materials that aren’t available from your US; they are only accessible from China,” DiLoreto suggests.“We have now to